ScienceDex / Researcher record
Emmy Okello
FY2026 NIH rank #12,684
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,019,653 | 2 | #5,227 |
| 2025 | $1,982,758 | 2 | #6,843 |
| 2026 | $1,622,367 | 5 | #12,684 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20242 records
- FY20252 records
- FY2026 · selected5 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12532504Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award records by amount
NIH award records listing Emmy Okello as a PI. Multi-PI records show the full award amount for context.
- 3R33HL166441-04S1R33Co-investigatorIntramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE)Cincinnati Children's Hospital Medical Center · Pediatrics (investigator's affiliation)$680.9Kaward amount
- 5R33HL166441-04R33Co-investigatorIntramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE)Cincinnati Children's Hospital Medical Center · Pediatrics (investigator's affiliation)$643.2Kaward amount
- 3R33HL166441-04S3R33Co-investigatorIntramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE)Cincinnati Children's Hospital Medical Center · Pediatrics (investigator's affiliation)$135.7Kaward amount
- 5D43TW012255-05D43Co-investigatorReducing the Impact of Rheumatic Heart Disease across the Life Span: The Impact Program$100Kaward amount
- 3R33HL166441-04S2R33Co-investigatorIntramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE)Cincinnati Children's Hospital Medical Center · Pediatrics (investigator's affiliation)$62.6Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Emmy Okello as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardCincinnati Children's Hospital Medical Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5227
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Emmy Okello.